Frontiers in Pharmacology (Nov 2022)

Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy

  • Tian Tian

DOI
https://doi.org/10.3389/fphar.2022.1081912
Journal volume & issue
Vol. 13

Abstract

Read online

No abstracts available.

Keywords